The following companies made the news for the Health Care Industry on Monday, June, 28, 2010 Cardiome, (NASDAQ:CRME): BRINAVESS, Intravenous or IV Vernakalant announced, EMA issued positive opinion for marketing approval for conversion of recent onset atrial fibrillation to sinus rhythm in adults, marketing authorization is expected later this year and will include  27 EU [...]



